Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • vebaev
    Senior Res.
    • Oct 2008
    • 112

    miRNA read counts regarding DE

    Hi,
    I'm using several software to annotate known miRNAs from deep-seq. Regarding differential expression, most of the software point only miRNAs present in all the samples and their fold change.

    I was thinking what about for examples if some miRNA are present in my control replicas (2) and have read counts, and in the other 2 samples replicas this miRNA is not present at all?
    Does it mean something or in DE analysis should be considered miRNAs presented on some level in all samples?

    Thanks!
    ------------
    SMART - bioinfo.uni-plovdiv.bg
  • Simon Anders
    Senior Member
    • Feb 2010
    • 995

    #2
    What kind of software are you talking about? If you want to test for differential expression of miRNA between conditions, use the same tools as used for mRNA, i.e., DESeq, edgeR or BaySeq. Neither of these has any problem if counts are zero for some samples.

    Comment

    • vebaev
      Senior Res.
      • Oct 2008
      • 112

      #3
      I mean when I got that some miRNA are zero in one sample and a specific reads in other sample should I look them at all? Is it biologically meaningful when in one sample is zero?
      ------------
      SMART - bioinfo.uni-plovdiv.bg

      Comment

      • NicoBxl
        not just another member
        • Aug 2010
        • 264

        #4
        what is the number of reads in the other samples ?

        Comment

        • vebaev
          Senior Res.
          • Oct 2008
          • 112

          #5
          I have checked and the other reads are quite low, so I'm planning to discard these entries
          ------------
          SMART - bioinfo.uni-plovdiv.bg

          Comment

          • Simon Anders
            Senior Member
            • Feb 2010
            • 995

            #6
            If you use a tool like DESeq, edgeR, BaySeq, you don't need to worry about this at all; the tools will judge themselves whether counts are too low to be significant; and for this, there it makes no difference whether the count is just very low or actually zero

            Comment

            • vebaev
              Senior Res.
              • Oct 2008
              • 112

              #7
              Yes, I'm exploring for example DESeq, but I have problems creating the tabular input format for my 4 samples (2 controls and 2 conditions).
              I do not know that to use to create it, should be tabular with readcounts, but miRNAs corresponding reads should be indentified first....so Im confused...what should I pipe into DESeq?

              Can you recommend me a tutorial or documentation, because I found all the things for DESeq with protein coding seqs where are more complex?
              ------------
              SMART - bioinfo.uni-plovdiv.bg

              Comment

              • NicoBxl
                not just another member
                • Aug 2010
                • 264

                #8
                the input of DESeq is a data.frame ( column : sample, row : miRNA )

                ex:
                Code:
                         Sample1     Sample2         Sample3
                miR-1      10              20              15
                miR-2      100             30              109

                Comment

                • vebaev
                  Senior Res.
                  • Oct 2008
                  • 112

                  #9
                  Thanks I will try that and post here my progress
                  ------------
                  SMART - bioinfo.uni-plovdiv.bg

                  Comment

                  • vebaev
                    Senior Res.
                    • Oct 2008
                    • 112

                    #10
                    PS
                    should I worry how to list columns (order) sample1 2 3 , as they are 2 controls and 2 conditions?
                    ------------
                    SMART - bioinfo.uni-plovdiv.bg

                    Comment

                    • NicoBxl
                      not just another member
                      • Aug 2010
                      • 264

                      #11
                      no

                      you've to read the DESeq doc : http://www-huber.embl.de/users/anders/DESeq/

                      Comment

                      • vebaev
                        Senior Res.
                        • Oct 2008
                        • 112

                        #12
                        Thanks will do that now
                        ------------
                        SMART - bioinfo.uni-plovdiv.bg

                        Comment

                        • vebaev
                          Senior Res.
                          • Oct 2008
                          • 112

                          #13
                          as a total number of reads for library it should be considered total number of mapped reads (sum of all mIR counts in column) or total number of reads from sequencing?
                          ------------
                          SMART - bioinfo.uni-plovdiv.bg

                          Comment

                          • NicoBxl
                            not just another member
                            • Aug 2010
                            • 264

                            #14
                            Originally posted by vebaev View Post
                            as a total number of reads for library it should be considered total number of mapped reads (sum of all mIR counts in column) or total number of reads from sequencing?
                            same question

                            Comment

                            • vebaev
                              Senior Res.
                              • Oct 2008
                              • 112

                              #15
                              From what I have read I have end up with this - the total number is probably the total bumber of mapped reads, please correct me if I'm wrong!
                              ------------
                              SMART - bioinfo.uni-plovdiv.bg

                              Comment

                              Latest Articles

                              Collapse

                              • mylaser
                                Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                                by mylaser
                                Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
                                If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
                                This guide explains everything you need to know about...
                                Today, 01:13 AM
                              • SEQadmin2
                                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                                by SEQadmin2



                                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                                ...
                                07-09-2026, 11:10 AM
                              • SEQadmin2
                                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                                by SEQadmin2



                                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                                07-08-2026, 05:17 AM

                              ad_right_rmr

                              Collapse

                              News

                              Collapse

                              Topics Statistics Last Post
                              Started by SEQadmin2, 07-09-2026, 10:04 AM
                              0 responses
                              16 views
                              0 reactions
                              Last Post SEQadmin2  
                              Started by SEQadmin2, 07-08-2026, 10:08 AM
                              0 responses
                              10 views
                              0 reactions
                              Last Post SEQadmin2  
                              Started by SEQadmin2, 07-07-2026, 11:05 AM
                              0 responses
                              22 views
                              0 reactions
                              Last Post SEQadmin2  
                              Started by SEQadmin2, 07-02-2026, 11:08 AM
                              0 responses
                              31 views
                              0 reactions
                              Last Post SEQadmin2  
                              Working...